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INTRODUCTION 
 
Vascular aging is accompanied by dysfunctional 
vascular phenotypes including endothelial dysfunction 
and arterial stiffening that play critical causal roles in 
the majority of cardiovascular diseases [1–3]. Cellular 
senescence, an irreversible cell cycle arrest, in 
endothelial cells critically contributes to this vascular 
aging. Senescent endothelial cells show impaired 
homeostatic functions including nitric oxide production, 
vascular inflammation, cytoskeleton integrity, 
angiogenesis, proliferation, and cell migration [4, 5]. 
Senescent cells can also propagate their senescence 
phenotypes to healthy neighboring cells by releasing 
reactive oxygen species as well as inflammatory 
mediators, including but not limited to, interleukin(IL)-
6, IL-1, and IL-8 [1, 6, 7]. The accumulation of 
senescent cells in vessels leads to chronic inflammation 
and oxidative stress resulting in endothelial dysfunction 
and arterial stiffening [1].  
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Cellular senescence of endothelial cells causes vascular dysfunction, promotes atherosclerosis, and contributes 
to the development of age-related vascular diseases. Sirtuin 6 (SIRT6), a conserved NAD+-dependent protein 
deacetylase, has beneficial effects against aging, despite the fact that its functional mechanisms are largely 
uncharacterized. Here, we show that SIRT6 protects endothelial cells from senescence. SIRT6 expression is 
progressively decreased during both oxidative stress-induced senescence and replicative senescence. SIRT6 
deficiency leads to endothelial dysfunction, growth arrest, and premature senescence. Using genetically 
engineered endothelial cell-specific SIRT6 knockout mice, we also show that down-regulation of SIRT6 
expression in endothelial cells exacerbates vascular aging. Expression microarray analysis demonstrated that 
SIRT6 modulates the expression of multiple genes involved in cell cycle regulation. Specifically, SIRT6 appears to 
regulate the expression of forkhead box M1 (FOXM1), a critical transcription factor for cell cycle progression 
and senescence. Overexpression of FOXM1 ameliorates SIRT6 deficiency-induced endothelial cell senescence. In 
this work, we demonstrate the role of SIRT6 as an anti-aging factor in the vasculature. These data may provide 
the basis for future novel therapeutic approaches against age-related vascular disorders. 
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Sirtuins are mammalian homologs of the yeast Sir2 
protein that is known to mediate chromatin silencing, 
DNA repair, and longevity [8]. There are seven known 
sirtuins in mammals. Endothelial cells express all sirtuin 
types [9]. Among the seven known sirtuins, sirtuin 1 
(SIRT1) is the most extensively analyzed sirtuin in 
endothelial cells and is known to be an important 
regulator of vascular endothelial aging by preventing 
DNA damage, cell cycle arrest, and oxidative stress 
[10]. SIRT1 exerts its effects by regulating endothelial 
nitric oxide synthase (eNOS), liver kinase B1, p53, 
angiotensin II type 1 receptor, and Forkhead box O 
(FOXO) 1 [11, 12]. There has been some research on 
the role of SIRT6 in the vasculature, but the research 
has not been as extensive as it has been for SIRT1. 
SIRT6, a nuclear and cytosolic protein, has NAD
+
-
dependent deacetylase [13] and/or mono-ADP-
ribosyltransferase [14] activities in many cell types. 
Loss of SIRT6 is known to associate with vascular 
endothelial dysfunction, senescence, and inflammation 
[15, 16], whereas induction of SIRT6 expression by 
exogenous vector-driven SIRT6, antioxidant, and anti-
inflammatory signals prevents or ameliorates 
endothelial dysfunction, senescence, and inflammation 
[16, 17]. The protective effects of SIRT6 on endothelial 
function are known to occur by inhibition of ICAM-1, 
PAI-1, p21Cip1/Waf1, and NF-κB signaling and 
sustaining high eNOS levels [11]. However, the more 
descriptive mechanism underlying the protective role of 
SIRT6 in endothelial cells is yet to be explored. In the 
present study, we investigated the role of SIRT6 in 
relation to the senescent phenotypes of endothelial cells 
and the pathway responsible for the SIRT6-associated 




SIRT6 expression is downregulated in senescent 
endothelial cells 
 
To examine the effect of cellular senescence on SIRT 
expression, we induced oxidative stress-induced 
senescence of human umbilical vein endothelial cells 
(HUVECs) by treatment with 200 μM H2O2 and 
validated the cellular senescence using senescence-
associated β-galactosidase (SA β-gal) assay (Figure 
1A). SA β-gal-positive endothelial cells gradually 
increased over time after H2O2 treatment, and 23% and 
51% of cells were SA β-gal positive on day 3 and day 
5, respectively (Figure 1B). Western blot analysis 
showed that SIRT1 and SIRT6 expression was 
significantly reduced on days 3, 5, and 10 following 
H2O2 treatment (Figure 1C). When approximately 73% 
of HUVECs were SA β-gal positive, SIRT6 expression 
was almost undetectable. Compared to SIRT1 and 
SIRT6, SIRT3 expression increased on days 3, 5, 10 
after H2O2 treatment (Figure 1C). To confirm the 
expression pattern of SIRTs in senescent endothelial 
cells, we used another senescence model (i.e. 
replicative senescence achieved by repeated passage) 
to show that cell proliferation stopped and cells 
entered senescence. We compared SIRT expression in 
young cells (population doubling level 8, PDL8) to 
that in old cells (PDL36) using western blot analysis. 
Replicative senescence in HUVECs was confirmed 
using the SA β-gal assay (Figure 1D). The percentage 
of SA β-gal-positive HUVECs in PDL36 was 77% 
(Figure 1E). In keeping with the pattern of SIRT 
expression in the oxidative stress-induced senescence 
of endothelial cells, old endothelial cells showed a 
clear decrease in SIRT1 and SIRT6 expression and an 
increase in SIRT3 expression (Figure 1F). To study 
whether the downregulation of SIRT1, SIRT3, and 
SIRT6 expression affected endothelial cell senescence, 
HUVECs were treated with SIRT1, SIRT3, and SIRT6 
siRNA. SIRT1, SIRT3, and SIRT6 knockdown with 
siRNA treatment was confirmed by western blot 
analysis (Figure 2A). SIRT1 and SIRT6 
downregulation significantly increased the population 
of SA β-gal-positive cells 6 d after siRNA treatment, 
but SIRT3 knockdown did not induce endothelial 
senescence (Figure 2B, 2C). The number of SA β-gal 
positive cells in SIRT6 knockdown cells was 2.6-fold 
higher than that in SIRT1 knockdown cells. We 
confirmed SIRT6 knockdown-induced senescence 
using a different sequence of SIRT6 siRNA 
(siSIRT6*, Supplementary Figure 1A–1D). These data 
suggest that the downregulation of SIRT6 expression 
itself is enough to induce endothelial cell senescence.  
 
SIRT6 is involved in the maintenance of endothelial 
cell function 
 
Senescent endothelial cells have impaired angiogenic 
function and are susceptible to inflammatory responses. 
To evaluate the effect of SIRT6 knockdown on capillary 
tube formation and inflammation in HUVECs, cells 
were transfected with 25 nM control, SIRT1, or SIRT6 
siRNA. When endothelial cells were cultured on 
Matrigel, the cells formed capillary-like tube network. 
SIRT1 and SIRT6 siRNA-transfected HUVECs on 
Matrigel showed reduced branch points and very short 
tubes (Figure 3A). Moreover, SIRT6 knockdown 
inhibited eNOS and KLF2 expression (Figure 3B), 
which play essential roles in maintaining endothelial 
integrity [18, 19]. Depletion of SIRT6 resulted in an 
increase in the inflammatory responses of endothelial 
cells (Figure 3C–3E). SIRT6 knockdown increased 
ICAM-1 expression but not E- and P-selectin 
expression. TNF-α-treated HUVECs highly expressed 
ICAM-1 and E-selectin. Interestingly, SIRT6 siRNA 
treatment upregulated TNF-α-induced ICAM-1 and E-
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selectin expression compared to control siRNA 
treatment with TNF-α. 
 
Downregulation of SIRT6 expression is associated 
with vascular senescence in mice 
 
Next, we focused on the effect of vascular senescence 
on in vivo SIRT6 expression using a paraquat dichloride 
x-hydrate (PQ)-induced senescence mouse model [20]. 
Injection of PQ, a herbicide that induces oxidative 
stress, in mice resulted in senescence of the thoracic 
artery. Intraperitoneal treatment of PQ for 3 d 
significantly induced SA β-gal-positive cells in thoracic 
arteries (Figure 4A, 4B). Using immunofluorescence, 
we checked whether PQ-induced vascular senescence 
affected SIRT6 expression in endothelial cells. SIRT6 
was mainly localized in the nucleus of vascular 
endothelial cells. PQ treatment decreased SIRT6 
expression in endothelial cells, which were located on 
the luminal surface and stained with CD31, an 
endothelial cell marker (Figure 4C). Subsequently, to 
understand whether selective depletion of SIRT6 
expression in aortic endothelial cells can stimulate 
vascular senescence, we generated conditional knockout 
mice in which SIRT6 expression is selectively ablated 
in endothelial cells by Cre-loxP recombination. Sirt6
f/f
 
mice possessing loxP sites flanking exon 2-3 of the 
Sirt6 gene were crossed with Tie2-Cre mice expressing 





mice. The depletion of SIRT6 
expression in thoracic aortic endothelial cells was 
confirmed by staining with an anti-SIRT6 antibody 





mice were the same as those of control 
mice. We examined senescence development in the 








Figure 1. SIRT6 expression is inhibited in endothelial cells during oxidative stress-induced or replicative senescence. (A) 
Representative image of SA β-gal-positive HUVECs 10 d after the addition of H2O2 (200 μM). (B) The percentage of SA β-gal-positive senescent 
HUVECs that were treated with 200 μM H2O2 for 1 h and then cultured for the indicated time to generate oxidative stress-induced 
senescence. The data represent the mean percentage ± SD (n = 3). *P < 0.01 vs. control. (C) Western blot images to analyze the expression of 
SIRT1, SIRT2, SIRT3, SIRT5, and SIRT6 in HUVECs at 1, 3, 5, or 10 d after addition of H2O2 (200 μM). (D) SA β-gal staining images for young 
(PDL8) and old (PDL36) cells. (E) The percentage of SA β-gal-positive HUVECs that were passaged to induce replicative senescence. The data 
are shown as the mean ± SD (n = 3). *P < 0.01 vs. young cells. (F) The expression of SIRTs in young and old HUVECs. An antibody recognizing 
β-actin was used as a loading control.  
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SA β-gal staining. Compared to control Sirt6
f/f
 mice, 
Sirt6 ablation in aortic endothelial cells did not affect 
vascular senescence. However, in PQ-treated mice,  





than in the aortas of control mice 
(Figure 4E, 4F). These data suggested that decreased 
SIRT6 expression is not sufficient to induce in vivo 
vascular senescence, but the downregulation of SIRT6 
may exacerbate vascular senescence together with 




Figure 2. Knockdown of SIRT6 expression induces endothelial cell senescence. (A) Western blot analysis showing the knockdown 
expression of SIRT1, SIRT3, and SIRT6 in HUVECs treated with SIRT1, SIRT3, and SIRT6 siRNAs, respectively. Total protein was extracted from 
cells 1 and 3 d after siRNA treatment. (B) The representative images obtained from SA β-gal-stained HUVECs. The cells transfected with the 
indicated siRNA (25 nM) were re-transfected with the siRNA 3 d after the first siRNA treatment. After 6 d from the first transfection, cells 
were stained for SA β-gal. (C) The percentage of SA β-gal-positive senescent cells at 6 d after siRNA transfection. The data are shown as the 
mean ± SD (n = 3). *P < 0.05 vs. control siRNA. 
 




Figure 3. Downregulated expression of SIRT6 induces endothelial cell dysfunction. (A) Effect of SIRT6 siRNA on in vitro tube 
formation in HUVECs. HUVECs transfected with 25 nM of the indicated siRNA were cultured on Matrigel to check in vitro angiogenesis activity 
of endothelial cells. The representative micrographs of tube formation in HUVECs. (B) Western blot analysis showing the effect of SIRT6 siRNA 
on the expression of eNOS and KLF2. β-Actin was used as a loading control. (C, D) Representative flow cytometry plots showing the effect of 
SIRT6 knockdown on cell surface expression of ICAM-1, E-selectin, and P-selectin. HUVECs transfected with 25 nM control or SIRT6 siRNA 
were treated or not treated with TNF-α (50 ng/mL) for 4 h. Cells were stained with the fluorochrome-conjugated antibodies and analyzed by 
flow cytometry. (E) Graphs showing ICAM-1, E-selectin, and P-selectin expression levels in the cells. Data were obtained by analyzing the 
mean fluorescence intensity of each inflammatory molecule on HUVECs, which were differentially treated with control or SIRT6 siRNA in the 
absence and presence of TNF-α. *P < 0.01 vs. control siRNA. #P < 0.01 vs. control siRNA with TNF-α. 
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Figure 4. SIRT6 expression is downregulated in mouse senescent aorta, and endothelial-specific Sirt6 knockout in mouse 
deteriorates oxidative stress-induced senescence in the aorta. (A) Images from SA β-gal staining of thoracic aorta from C57/BL6 mice 
injected with PBS or PQ. (B) Graph showing the relative SA β-gal-positive areas in PBS- and PQ-treated thoracic aortas. SA β-gal-positive areas 
were quantified using ImageJ. The experiment was repeated twice. Data represent the mean percentage ± SD (n = 4). *P < 0.05 vs. control 
treatment. (C) Double immunofluorescence staining showing SIRT6 and CD31 expression in control and PQ-treated thoracic aortas. The 
sections were co-stained with anti-SIRT6 and anti-CD31 antibodies. DAPI was used to stain nuclei. Arrows indicate nuclei of endothelial cells. 




 mouse thoracic aortas. The 
sections were co-stained with anti-SIRT6 and anti-CD31 antibodies. DAPI was used to stain nuclei. Arrows indicate nuclei of endothelial cells. 














 mice injected with PBS or PQ. The percentage of SA β-gal-positive areas was quantified using ImageJ. The experiment was 
repeated twice. Data are shown as the mean ± SD (n = 4). *P < 0.05 vs. control Sirt6
f/f
. #P < 0.05 vs. Sirt6
f/f
 treated with PQ. 
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Genes associated with cellular growth and 
proliferation as top-affected genes by SIRT6 
knockdown 
 
To understand the mechanistic pathways linked to 
SIRT6 depletion-induced endothelial cell senescence, 
we compared the gene transcription profiles of SIRT6 
siRNA-treated HUVECs with control cells using 
microarray analysis. We found 1,443 differentially 
expressing genes including 691 downregulated and 
752 upregulated genes with more than 1.3-fold change 
(Supplementary Table 1). Ingenuity pathway analysis 
revealed that the top five molecular and cellular 
functions were cell cycle, DNA 
replication/recombination/repair, cell death/survival, 
cellular growth/proliferation, and cell movement 
(Figure 5A). Moreover, the top five groups of genes in 
terms of physiological system development and 
function were associated with organismal survival, 
connective tissue development and function, tumor 
morphology, skeletal and muscular system 
development and function, and cardiovascular system 
development and function (Figure 5B). Analysis of 
canonical pathways showed that the top five pathways 
regulated by SIRT6 were cell cycle control of 
chromosomal replication, estrogen-mediated S phase 
entry, GADD45 signaling, ATM signaling, and p53 
signaling (Figure 5C). Up- or down-regulated genes 
involved in cell cycle transition regulation are 
presented as a heatmap and as a regulatory network 
(Figure 5D, 5E). We found that there was a significant 
increase in the expression of the cell cycle inhibitor 
CDKN1A (p21 Cip1) and a decrease in the expression 
of CDK2, CDK4, CCNA1, CCNA2, CCNE1, CCNE2, 
and FOXM1 in SIRT6 knockdown HUVECs. Taken 
together, these data suggest that SIRT6 knockdown-
induced senescence occurred due to changes in the 
regulation of genes involved in cell cycle and that 
SIRT6 played a critical role in maintaining cell cycle 
progression in endothelial cells. The results from the 
microarray analysis also provided FOXM1 as a 
potential novel gene associated with SIRT6-induced 
cell cycle arrest in endothelial cells (Figure 5E).  
 
SIRT6 knockdown induces cell growth arrest in 
endothelial cells 
 
To understand whether SIRT6 plays a regulatory role 
in endothelial cell division, growth of SIRT6 siRNA-
treated HUVECs was compared to that of control 
siRNA-treated cells via the MTT assay and live cell 
counting using trypan blue (Figure 6A and 
Supplementary Figure 1E). Treatment with SIRT6 
siRNA significantly inhibited HUVEC proliferation. 
Cell cycle analysis showed that the incubation of cells 
with SIRT6 siRNA for 3 d resulted in cell cycle arrest 
(Figure 6B). We observed a significant increase in the 
number of cells in the G0/G1 phase among SIRT6 
knockdown cells, along with a decrease in the number 
of cells in S and G2/M phases, indicating that SIRT6 
plays an important role in cell cycle progression in 
endothelial cells. Next, we investigated whether the 
depletion of SIRT6 expression affected the expression 
of cell cycle regulatory factors (Figure 6C). The 
expression of the cyclin-dependent inhibitor p21 was 
highly upregulated on day 1 after SIRT6 siRNA 
transfection. In addition to the increase in p21 
expression, CDK2, CDK4, and phosphorylated forms 
of Rb expression were significantly downregulated in 
cells transfected with SIRT6 siRNA compared to cells 
transfected with control siRNA. We also saw that 
SIRT6 knockdown inhibited CDK1 phosphorylation. 
These data suggested that SIRT6 expression is 
important for maintaining and controlling factors 
involved in cell cycle regulation in vascular 
endothelial cells. Together with the expression and 
activities of cell cycle regulators, cell cycle arrest can 
be affected by DNA damage. To determine whether 
SIRT6 knockdown induced DNA damage, we 
quantified γH2AX and 53BP1 foci, sensitive markers 
of DNA damage, in HUVECs treated with SIRT6 
siRNA for 3 d (Figure 7A). Approximately 90% and 
20% of cells were γH2AX foci positive among 
etoposide (a DNA topoisomerase II inhibitor)- and 
H2O2-treated cells, respectively (Figure 7B). 
However, SIRT6 siRNA-treated cells did not show a 
significant increase in γH2AX foci-positive cells. In 
addition, the number of 53BP1 foci-positive cells was 
unchanged upon SIRT6 knockdown, although H2O2 
significantly stimulated 53BP1 foci formation (Figure 
7A, 7B). To confirm that SIRT6 downregulation was 
not directly linked to DNA damage, we performed 
alkaline comet assay that is able to detect single and 
double-stranded DNA breaks in single cell level. 
Treatment of HUVECs with H2O2 for 1 h significantly 
induced DNA damages resulting in comet tail, 
migrating DNA fragments, from the nucleoid (Figure 
7C, 7D). However, SIRT6 knockdown did not  
induce DNA strand breaks. No differences in the tail 
DNA percent or tail moment were observed in control 
and SIRT6 siRNA-treated cells 3 days after 
transfection (Figure 7C, 7D). We also assessed the 
level of DNA damage response proteins, 
phosphorylated p53. Phosphorylation of p53 at serine 
15 can be induced by DNA damage sensing proteins, 
ataxia telangiectasia mutated kinase and ataxia 
telangiectasia and Rad3-related kinase [21]. SIRT6 
siRNA treatment did not stimulate the 
phosphorylation of p53 (Supplementary Figure 2). 
These data demonstrate that downregulated SIRT6 is 
closely associated with cell cycle arrest not 
attributable to prevalent DNA damage.  
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SIRT6 knockdown-induced senescence is associated 
with a decrease in FOXM1 expression, and 
FOXM1C induction ameliorates the senescence 
phenotype in endothelial cells  
 
FOXM1 is a master regulator essential for different 
phases of the cell cycle [22]. FOXM1 repression was 
observed during cellular aging, and recovery of its 
expression prevented senescence [23–25]. Microarray 
analysis revealed that FOXM1 was one of the factors 
affected by SIRT6 knockdown. Additionally, western 
blot analysis using senescent aortas collected from PQ-
treated mice also supported the idea that together with a 




Figure 5. Genes associated with cell proliferation are the genes most affected by SIRT6 knockdown in endothelial cells. 
HUVECs were transfected with 25 nM of control or SIRT6 siRNA. After 3 d, total RNA was isolated, and the gene expression profile was 
assessed with the Illumina bead chip analysis. The identified genes that were differentially regulated by SIRT6 knockdown were analyzed by 
the Ingenuity Pathway Analysis program to determine the SIRT6 gene function in endothelial cells. (A, B) Top five groups of genes categorized 
by molecular and cellular functions (A) and physiological system development and function (B). (C) Top five canonical pathways affected by 
SIRT6 knockdown. (D) Heat map showing the genes specifically involved in cell cycle transition regulation. Rows show individual genes, and 
columns show triplicate samples. Up- and downregulated genes are shown in red and green, respectively. (E) A gene functional association 
network for the genes involved in cell cycle transition regulation. The intensity of the node colors (red and green) indicates the degree of up- 
and downregulation.  
 
www.aging-us.com 20954 AGING 
repressed in senescent aortas (Figure 8A, 8B). To 
clarify the effect of SIRT6 knockdown on FOXM1 
expression, we checked the mRNA and protein 
expression of FOXM1 in SIRT6 knockdown-induced 
senescent HUVECs (Figure 8C, 8D and Supplementary 
Figure 1F). According to real-time RT-PCR and 
western blot analyses, decreased SIRT6 expression 
reduced FOXM1 expression, indicating that FOXM1 
expression was closely linked to SIRT6 expression in 
HUVECs. When HUVECs were treated with FOXM1 
siRNA (Figure 8E, 8F), the number of SA β-gal-
positive cells increased, suggesting that repression of 
FOXM1 expression itself can induce endothelial 
senescence (Figure 8G, 8H). Human FOXM1 gene 
consists of ten exons, of which exons Va and VIIa are 
alternatively spliced [26, 27]. There are four FOXM1 
isoforms, FOXM1A, FOXM1B, FOXM1C, and 
FOXM1D (Supplementary Figure 3A). To identify 
which isoforms are expressed in HUVECs, we 
performed RT-PCR using primer sets flanking exon Va 
or VIIa. Primers P1 and P2 predominantly amplified 
250 bp of FOXM1A or FOXM1C forms containing Va 
exon. The most of PCR products amplified by primers 
P3 and P4 were 379 bp fragment that did not have  
VIIa exon (Supplementary Figure 3B). These data 




Figure 6. SIRT6 knockdown significantly induces cell proliferation in endothelial cells. (A) MTT assay showing the effect of SIRT6 
knockdown on endothelial cell proliferation. HUVECs were transfected with 25 nM control or SIRT6 siRNA and incubated for the indicated 
number of days. *P < 0.01 vs. control siRNA. (B) Cell cycle analysis indicating that SIRT6 siRNA induces cell cycle arrest in endothelial cells. 
HUVECs were transfected with 25 nM control or SIRT6 siRNA. After 3 d, cells were stained with PI and analyzed using flow cytometry. 
Graphs show the mean percentage ± SD of cells in G0/G1, S, and G2/M phases. *P < 0.05 vs. control siRNA. **P < 0.01 vs. control siRNA.  
(C) Western blot analysis to determine the effect of SIRT6 knockdown on the expression of cell cycle regulators. β-Actin was used as a 
loading control.  
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expressed in HUVECs. To investigate whether 
restoration of FOXM1C expression in SIRT6 siRNA-
treated HUVECs can ameliorate cellular senescence, we 
generated lentivirus encoding FLAG-tagged FOXM1C 
and infected HUVECs with this lentivirus. We 
confirmed SIRT6 knockdown and the induction of 
FLAG-FOXM1C by western blotting (Figure 8I). SA β-
gal staining showed that the rescued FOXM1C 
expression significantly blocked SIRT6 knockdown-




Strategies to slow down the aging process at a systemic 
or tissue level have attracted a great deal of attention 
because there is evidence to suggest that slowed aging 
results in a prolonged lifespan by delaying and 
preventing disease onset for chronic conditions in 
adulthood and old age [28, 29]. Cardiovascular disease, a 
major cause of death, is an age-related disease. Therefore, 
it is important to understand the mechanisms underlying 
vascular aging. One of the most promising gene targets 
for slowing down vascular aging is SIRT1 [28]. Sirtuin-
activating compounds, including resveratrol and other 
synthetic compounds, have been tested in clinical trials to 
assess their ability to prevent aging and age-related 
diseases [29]. Although other types of sirtuins are also 
thought to be involved in the aging process, few studies 
have explored the effect of other sirtuins on vascular 
aging. Herein, we show SIRT6 is significantly 
downregulated in senescent HUVECs and that siRNA-
mediated knockdown of SIRT6 expression induces 
endothelial cell senescence. We also showed that 
inhibition of SIRT6 expression impairs in vitro 
angiogenesis and eNOS and KLF2 expressions that play 
an important role in the maintenance of endothelial cell 
function. Moreover, SIRT6 inhibition increases ICAM-1 




Figure 7. SIRT6 knockdown does not directly induce DNA damage at the times when the cell cycle is inhibited. (A) 
Representative images for the effect of SIRT6 knockdown on the formation of DNA damage foci. HUVECs were transfected with 25 nM 
control or SIRT6 siRNA. H2O2 (200 μm) and etoposide (10 μm) were used as positive controls to induce DNA damage. After 3 d, cells were 
stained with anti-γ-H2AX and anti-53BP1 antibodies. DAPI was used to stain nuclei. Scale bars represent 20 μm. (B) Quantification of DNA-
damaged cells. Cells with more than ten γ-H2AX or five 53BP1 foci were scored. Data are expressed as the mean ± SD (n = 3). *P < 0.05 vs. 
control siRNA. **P < 0.001 vs. control siRNA. (C) Comet images of HUVECs treated with control or SIRT6 siRNA. HUVECs were treated with  
25 nM control or SIRT6 siRNA. After 3 d, dissociated single cells were subjected to alkaline comet assay. Cells treated with H2O2 for 1 h were 
used as positive control. (D) Analysis of comet images. Percent DNA in the tail and tail moment of damaged cells were quantified using 
OpenComet. Data are expressed as the mean ± SD (n = 3). *P < 0.05 vs. control siRNA. **P < 0.01 vs. control siRNA.  
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Figure 8. Downregulated SIRT6 expression inhibits FOXM1 expression, which is closely related to endothelial cell 
senescence. (A) Western blot analysis showing downregulation of FOXM1 and SIRT6 expression in thoracic aortas of mice treated with PBS 
or PQ. (B) Relative SIRT6 and FOXM1 protein expression in control and PQ-treated aortas. The protein expression was quantified using Bio-
Rad Image Lab software. Relative expression was normalized to β-actin. (C) Real-time RT-PCR analysis indicating that SIRT6 knockdown 
transcriptionally inhibited FOXM1 expression. (D) Western blot analysis presenting the effect of SIRT6 knockdown on FOXM1 protein 
expression. (E) Real-time RT-PCR confirming the efficient knockdown of FOXM1 expression in endothelial cells by 25 nM FOXM1 siRNA. (F) 
Western blot analysis to show the knockdown of FOXM1 protein in FOXM1 siRNA-treated HUVECs. (G) Representative images of SA β-gal-
positive senescent HUVECs that were transfected with control or FOXM1 siRNA. (H) Quantification of data from (G). The mean percentage of 
SA β-gal-positive cells was calculated, and error bars indicate SD (n = 3). *P < 0.001 vs. control siRNA. (I) Western blot analysis showing 
overexpression of FOXM1 in control or SIRT6 siRNA-treated endothelial cells. HUVECs were infected with 10 MOI of lentivirus vector 
encoding FLAG-tagged SIRT6. One day later, cells received the first transfection with 25 nM control or SIRT6 siRNA. Next, cells were 
transfected with the same siRNA 3 d after the first transfection. Six days after the first transfection, cells were analyzed for SIRT6 and FLAG-
tagged FOXM1 expression. β-Actin was used as a loading control. (J) Representative images showing that overexpression of FOXM1 inhibited 
SIRT6 knockdown-induced endothelial cell senescence. Cells were stained for SA β-gal. (K) Quantification of data from (J). Data are expressed 
as the mean ± SD (n = 3). *P < 0.001 vs. control siRNA. #P < 0.01 vs. SIRT6 siRNA. 
 
www.aging-us.com 20957 AGING 
E-selectin expression. All of the phenotypes that we 
observed in SIRT6 siRNA-treated HUVECs are 
equivalent to senescent phenotypes (e.g. reduced capacity 
of new vessel formation, endothelial dysfunction, and 
high inflammatory responses) [30]. SIRT6 is known to 
physically interact with the NF-κB subunit RELA to 
negatively regulate NF-κB-dependent transcription via 
histone H3K9 deacetylation [31]. Therefore, SIRT6 
downregulation can lead to inappropriate NF-κB 
activation, resulting in cell senescence and inflammation. 
We also found that senescence also resulted in an 
increase in SIRT3 expression. SIRT3 can deacetylate 
FOXO3 to upregulate a set of genes that are essential for 
mitochondrial homeostasis. Thus, SIRT3-activated 
signaling pathways preserve mitochondrial reserve 
capacity by the clearance of defective mitochondria and 
the maintenance of mitochondrial mass and ATP 
production [32]. In the present study, increased SIRT3 
expression during senescence may be the result of efforts 
made by endothelial cells to protect the progressive 
accumulation of defective mitochondria, a common 
feature of aged cells. 
 
A previous publication using an ApoE
-/-
 atherosclerotic 
animal model showed that SIRT6 mRNA and protein 
levels were downregulated in atherosclerotic aortas and 
that SIRT6 has a protective role against the development 
of atherosclerosis. Our in vivo vascular aging model also 
showed that SIRT6 expression is significantly lower in 
the endothelial cells of senescent mouse aorta, which is 
consistent with our HUVEC data. In endothelial cell-





were no differences between the control and SIRT6-
deficient mouse aortas. Under the pathological condition 
of oxidative stress, endothelial cell-specific SIRT6 
deficiency exacerbated PQ-induced senescence in the 
aorta. Our data suggest that there may be a 
complementary mechanism to counteract the effect of 
SIRT6 deficiency in vivo and that SIRT6 depletion under 
conditions of stress makes vessels more vulnerable to 
senescence. Similar to our findings, a study using 
endothelial-specific Sirt6 knockout mice reported that 
SIRT6 deficiency did not produce statistically significant 
effects on blood pressure, but Sirt6 knockout mice 
treated with deoxycorticosterone acetate/salt exhibited a 
more significant increase in blood pressure than that in 
control mice [33].  
 
Cellular senescence involves a programed cell cycle 
arrest. Our microarray analysis supports the hypothesis 
that SIRT6 plays an important role in cell cycle 
regulation. The top signaling pathway associated with 
the SIRT6 function was cell cycle control. SIRT6 
siRNA treatment negatively affected endothelial cell 
proliferation, and SIRT6 siRNA-treated cells were 
arrested in the G0/G1 phase. Depletion of SIRT6 
inhibited CDK2, CDK4, phosphorylated CDK1, and 
phosphorylated Rb expression while it also increased 
p21 expression. The cell cycle arrest 3 days after SIRT6 
siRNA transfection does not appear to be due to DNA 
damages. SIRT6 depletion itself did not induce single 
and double-strand DNA damage. However, we cannot 
completely rule out the accumulation of DNA damage 
during SIRT6 knockdown-induced senescence, which 
in turn can accelerate senescence. There are evidences 
supporting that SIRT6 is responsible for more efficient 
DNA damage repair [34–36]. In cells under oxidative 
stress, SIRT6 was recruited to the sites of DNA double-
strand breaks and promoted DNA repair by physical 
association and activation of PARP1 [34]. The study 
using 18 rodent species with diverse lifespans showed 
that deacetylase and mono-ADP ribosylase activities of 
SIRT6 were much higher in longer-lived species than 
in shorter-lived ones. The enzymatic activities directly 
contributed to lifespan extension and correlated 
positively with efficiency of DNA repair [35]. 
Rezazadeh et al. also demonstrated that SIRT6 
promoted repair of stress-induced DNA damage by 
transiently repressing transcription [36]. Therefore, 
instead of direct induction of DNA damage, cell cycle 
is sensitively controlled by SIRT6 protein levels. 
Inhibition of SIRT6 expression induces endothelial cell 
senescence via dysregulated expression of genes 
involved in cell cycle regulation. It would seem that 
exposing SIRT6 knockdown cells to additional stresses 
such as oxidative stress and cell-culture stress could 
accelerate senescence due to accumulation of DNA 
damage caused by a defect in DNA repair. 
 
Using microarray analysis, we have shown that FOXM1 
is responsible for SIRT6 deficiency-induced endothelial 
cell senescence. FOXM1 expression was significantly 
decreased in SIRT6 siRNA-induced senescent HUVECs 
as well as in the senescent aortas of mice. FOXM1 is a 
transcription factor of the forkhead family and FOXM1 
gene consists of 10 exons. To date, four isoforms, 
FOXM1A, FOXM1B, FOXM1C, and FOXM1D, were 
identified [26, 27]. Among them, FOXM1B, FOXM1C, 
and FOXM1D are transcriptionally active, and 
FOXM1A is inactive. FOXM1D plays a role in actin 
cytoskeleton regulation through ROCK2 interaction 
[27]. FOXM1B is predominantly overexpressed in 
tumor and FOXM1C is ubiquitously expressed in 
various cell types [26]. FOXM1B and FOXM1C is a 
key cell cycle regulator of both the G1/S phase 
transition and mitosis progression. FOXM1 expression 
levels correlate with the state of cell proliferation. 
FOXM1 is highly expressed in proliferating cells [26]. 
FOXM1 deficiency is associated with decreased cell 
proliferation as it inhibits many cell cycle-regulatory 
genes that are known to promote cell cycle progression 
through S, G2, and M phases [26].  
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Our RT-PCR data indicated that FOXM1C is 
predominant isoform expressed in HUVECs. Consistent 
with our results, Lam et al. also reported that FOXM1C 
is the isoform highly expressed in HUVECs [37]. 
Recovery of FOXM1C expression in HUVECs 
ameliorated SIRT6 siRNA-induced endothelial cell 
senescence. Similar to our findings, a study using aged 
fibroblasts also demonstrated repression of FOXM1 in 
aged cells and the protective effect of FOXM1 
induction on cellular aging phenotypes [23]. Compared 
to young mice, old mice have a defect in hepatocyte 
proliferation following partial hepatectomy [38]. 
Increased FOXM1 expression in aged FOXM1 
transgenic mice restored DNA replication and mitosis 
during liver regeneration, which was associated with the 
expression of genes that stimulate S phase and M phase 
progression [38]. FOXM1 deficiency is known to induce 
pleiotropic cell cycle defects such as impairments of 
mitotic entry, chromosome segregation, and mitotic exit 
[26]. The known targets of FOXM1 are G2/M phase-
promoting genes such as cyclin B1, Plk-1, Cdc25B 
phosphatase, and Aurora kinases. Additionally, CDK 
inhibitors p21 Cip1 and p27 Kip1 are elevated in 
FOXM1-deficient cells because of the downregulation 
of Skp2 and Cks1, which are important for the 
proteosomal degradation of p21 Cip1 and p27 Kip1 
proteins [39]. Our discovery that SIRT6 knockdown 
results in FOXM1 downregulation may be essential for 
elucidating the growth arrest phenotypes of senescent 




In conclusion, we present a in vitro and in vivo data 
showing that a decrease in SIRT6 expression is an 
important consequence of endothelial cell aging as well 
as a cause of endothelial senescence. Our findings 
suggest that the SIRT6 gene function is closely 
associated with cell cycle regulation and that the 
SIRT6-regulated FOXM1 pathway is a novel pathway 
responsible for endothelial cell senescence. The 
mechanism by which SIRT6 regulates FOXM1 
expression is unclear and should be further explored to 
aid our understanding of the protective role of SIRT6 in 
vascular aging. Moreover, our findings also highlight 
FOXM1 as a potential molecular target to prevent and 
treat cardiovascular diseases. 
 




HUVECs were purchased from Lonza (Walkersville, 
MD, USA) and maintained on 2% (w/v) gelatin-coated 
culture dish with Endothelial Growth Media-2 (EGM-2) 
BulletKit
TM
 medium (Lonza) in a 37° C humidified 
incubator with 5% CO2. HUVECs were sub-cultured 
before they reached 80% confluence to avoid 
irreversible contact-inhibition. HUVECs under eight 
population doublings (PDs) were used for the current 
experiments, with the exception of the induction of 
replicative senescence. The number of PDs was 
calculated using the following equation:  
 
 2 ( / ),PD log CH CS  (1) 
 
where CH is the number of viable cells at harvest and CS 
is the number of cells seeded as described previously 
[40]. PD levels were obtained from the sum of all 
previous PDs. To induce replicative senescence, 
HUVECs were continuously passaged to reach the 
indicated PD levels. Premature oxidative stress-induced 
senescence of HUVECs was induced by H2O2 
treatment. HUVECs under PDL 8 were treated with 200 
μM for 1 h. Then, cells were washed with EGM-2 and 
further incubated in EGM-2 for the indicated time. To 
knockdown SIRT1, SIRT3, SIRT6, and FOXM1 
expression, HUVECs under PDL 8 were transfected 
with 25 nM of SIRT1, SIRT3, SIRT6, and FOXM1 
siRNAs, respectively, using Lipofectamine RNAiMax 
(Invitrogen, Carlsbad, CA, USA). Three days after the 
first siRNA transfection, cells were re-transfected with 
siRNA. SIRT1 (GAAGTTGACCTCCTCATTG), SIRT3 
(GTCCATATCTTTTTCTGTG), SIRT6 (GGAACA 
TGTTTGTGGAAGA), and SIRT6* (CTGGTCTCCAG 
CTTAAACA) siRNAs were obtained from Bioneer 
(Daejeon, Korea), and ON-TARGETplus FOXM1 
siRNA (2305) was purchased from GE Healthcare 










/J) and Tie2-Cre 
(Tie2
cre/+
, B6.Cg-Tg(Tek-cre)1Ywa/J) mice were 
purchased from the Jackson Laboratory (Sacramento, 
CA, USA). Sirt6
f/f
 mice were backcrossed with 
C57BL/6 mice to produce congenic strains. Then, 
Sirt6
f/f
 mice were crossed with Tie2-Cre mice 
expressing Cre recombinase under the control of a Tie2 




) deficient of 
endothelial cell SIRT6. Mice were genotyped by PCR 
according to the provider’s instruction. Sirt6
f/f 
mice 





 mice. C57BL/6 mice were obtained 
from Orient Bio Company (Seongnam, Korea). To 
induce senescence of aorta, male mice (8–9 weeks old) 
were intraperitoneally injected with 25 mg/kg PQ 
(Sigma-Aldrich, St. Louis, MO, USA). After 3 d, mice 
were anesthetized and sacrificed. After systemic 
perfusion with PBS, the thoracic aorta was excised and 
fixed with formalin or fixation buffer from the 
Senescence Cells Histochemical Staining Kit (Sigma-
 
www.aging-us.com 20959 AGING 
Aldrich). Animal care and experimental procedures 
were performed following approval from the 
Institutional Animal Care and Use Committee of CHA 
University (Approval No. IACUC160065). 
 
Lentiviral vector production and infection 
 
To deliver the FOXM1 gene into HUVECs, we generated 
a lentiviral vector encoding FOXM1 tagged with FLAG. 
Full length FOXM1 coding sequences were amplified by 
PCR from pCl-CMV-YFPc-FOXM1-puro/pCl-CMV-
FOXM1-YFPc-puro in a retroviral array library [41] and 
then cloned into a pENTR/D-TOPO vector (Invitrogen). 
Using Gateway recombination (Invitrogen), the FOXM1 
coding sequences were transferred into destination 
lentiviral vector, pHAGE-CMV-N-FLAG-HA-puro, to 
obtain an N-terminally FLAG- and HA-tagged FOXM1 
(pHAGE-CMV-N-FLAG-HA-FOXM1-puro) expressing 
vector. Lentiviral vector particles were produced using the 
Lenti-X HTX packaging system (Clontech Laboratories, 
Mountain View, CA, USA) according to the 
manufacturer’s instruction. Briefly, Lenti-X 293T cells 
were plated in a 100 mm dish at a density of 5×10
6
 cells 
and transfected with Lenti-X HTX packaging mix and 
pHAGE-CMV-N-FLAG-HA-FOXM1-puro using Xfect 
polymer. After 2 d, lentiviral supernatants were harvested 
and passed through a 0.45 μm filter to remove cell debris. 
After concentrating the lentivirus supernatants with the 
Lenti-X concentrator, the titer of virus particles was 
determined by Lenti-X GoStix (Clontech Laboratories). 
HUVECs were seeded in 60 mm dishes at 1×10
5
 cells. 
One day later, cells were fed with EGM-2 containing 5 
μg/mL of polybrene and treated with 10 multiplicity of 
infection (MOI) of lentivirus particles.  
 
SA β-gal staining 
 
SA β-gal activity was measured using Senescence Cells 
Histochemical Staining Kit (Sigma-Aldrich) according 
to the manufacturer’s instructions. Briefly, the fixed 
HUVECs and thoracic aortas were incubated with 
staining-mixture containing X-gal at 37° C without CO2 
until cells were stained blue. After washing with PBS, 
cells were covered with a 70% (v/v) glycerol solution. 
An image of positive SA β-gal cells and aortas was 
taken under a microscope, and cells were counted. The 
SA β-gal-positive areas in thoracic aortas were 
quantified using ImageJ (version 1.52a, National 
Institutes of Health, USA).  
 
Western blot analysis 
 
Total protein was isolated from cells using cold radio 
immunoprecipitation assay buffer containing a protease 
inhibitor cocktail (Roche Applied Science, Penzberg, 
Bavaria, Germany). A total of 50 μg of protein was 
subjected to SDS-PAGE, and the blots were transferred 
onto a polyvinylidene difluoride membrane. After 
blocking, the membranes were incubated with anti-
SIRT1 (Millipore, Temecula, CA, USA), anti-SIRT2 
(Cell Signaling Technology, Danvers, MA, USA), anti-
SIRT3 (Cell Signaling Technology), anti-SIRT5 
(Millipore), anti-SIRT6 (Cell Signaling Technology), 
anti-eNOS (Cell Signaling Technology), anti-KLF2 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
FOXM1 (Cell Signaling Technology), anti-β-actin (Santa 
Cruz Biotechnology), and anti-FLAG (Sigma-Aldrich) 
antibodies. Antibodies against cell cycle regulators and 
checkpoint molecules, including cyclin D1, cyclin D3, 
p18 INK4C, p21 Waf1/Cip1, p27 Kip1, CDK2, CDK6, 
phospho-RB, and phospho-p53 (Ser15), were purchased 
from Cell Signaling Technology. Immune-reactive 
protein bands were visualized by chemiluminescence 
using ECL reagents (GE Healthcare, Fairfield, CT, USA). 
Protein expression was imaged in a ChemiDoc XRS 
system (Bio-Rad Laboratories, Hercules, CA, USA).  
 
Real-time reverse transcription-polymerase chain 
reaction (RT-PCR) analysis 
 
At the indicated time after treatment with control, 
SIRT6, or FOXM1 siRNA, total RNAs were isolated 
using the RNeasy RNA isolation kit (Qiagen, Hilden, 
Germany) and reverse-transcribed using SuperScript® 
III First-Strand Synthesis System (Thermo Fisher 
Scientific, Waltham, MA, USA). Real-time RT-PCR 
was performed using the SYBR green reagent (Roche 
Applied Science) and an iCycler (Bio-Rad 
Laboratories). The primers used here were as follows: 
FOXM1 (5´-AAACCTGCAGCTAGGGATGT-3´ and 
5´-AGCCCAGTCCATCAGAACTC-3´) and β-actin 
(5´-GGACTTCGAGCAAGAGATGG-3´ and 5´-
AGCACTGTGTTGGCGTACAG-3´). PCR reactions 
were carried out in triplicate. The relative expression 
of FOXM1 mRNA was normalized to the β-actin 
mRNA. To analyze which spliced isoforms of FOXM1 
gene were expressed in HUVECs, we performed RT-
PCR. The used primers were as follows: P1 (5´-
CGTGGATTGAGGACCACTTT-3´), P2 (5´-GGATT 
CGGTCGTTTCTGCTG-3´), P3 (5´-GGGCGCACGG 
CGGAAGATGAA-3´), and P4 (5´-CCACTCTTC 
CAAGGGAGGGCTC-3´). The PCR products were 




The fixed aorta was embedded in paraffin, sectioned at 5 
μm thickness, and placed on Superfrost Plus Stain slides 
(Thermo Fisher Scientific). After deparaffinizing the 
sections, antigen retrieval of tissue sections was 
performed using an Epitope Retrieval Solution System 
(IHCworld, Woodstock, MD, USA) according to the 
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manufacturer’s instruction. The slides were incubated 
with a blocking buffer containing PBS with 4 % (w/v) 
BSA and 5% goat serum for 4 h at room temperature. 
Subsequently, the slides were incubated with primary 
antibodies such as anti-SIRT6 (Novus Biological, 
Littleton, CO, USA) and anti-CD31 (Santa Cruz 
Biotechnology) overnight at 4° C followed by secondary 
antibodies for 1 h at room temperature. Avidin-biotin-
horseradish peroxidase complex (Vector Laboratories 
Ltd., Peterborough, Cambridgeshire, UK) and Alexa 
Fluor 488 or 546 conjugated antibodies (Thermo Fisher 
Scientific) were used as secondary antibodies. The 
peroxidase signals were detected using DAB solution 
(Vector Laboratories Ltd.), and the slides were 
counterstained with hematoxylin, dehydrated, and 
mounted in permount mounting medium (Thermo Fisher 
Scientific). Slides with fluorochrome antibodies were 
mounted with ProLong antifade reagent (Invitrogen) 
containing 4’,6-diamidino-2-phenylindole (DAPI). To 
stain HUVECs for γ-H2AX and 53BP1 foci, siRNA-
treated HUVECs were cultured on gelatin-coated  
Lab-Tek chamber slides (Sigma-Aldrich). For the 
positive controls, HUVECs were treated with H2O2  
(200 μM) and etoposide (10 μM) for 1 h. Cells were then 
washed, and fresh medium was supplied. Following 
incubation for 3 d, cells were fixed with 3% (w/v) 
paraformaldehyde/2% (w/v) sucrose in PBS for 10 min 
at room temperature. Cells were then permeabilized with 
permeabilization buffer containing 0.5% (v/v) Triton X-
100, 20 mM HEPES-KOH (pH 7.9), 50 mM NaCl, 3 
mM MgCl2, and 300 mM sucrose, followed by 
incubation with anti-53BP1 (BD Biosciences, San Jose, 
CA, USA) or anti-γ-H2AX (Millipore) antibodies. Next, 
53BP1 and γ-H2AX proteins were visualized by 
treatment with an Alexa Fluor 488 conjugated anti-
mouse antibody (Invitrogen).  
 
Flow cytometry analysis 
 
Antibodies used for flow cytometry were purchased 
from BD Pharmingen (San Jose, CA, USA). Control or 
SIRT6 siRNAs were transfected into HUVECs at a 
concentration of 25 nM. After 3 d, the cells were 
treated with 50 ng/mL of rhTNF-α (R&D Systems, 
Minneapolis, MN, USA) for 4 h and prepared as a 
single cell suspension. Cells were then incubated  
with anti-E-selectin-phycoerythrin (PE), anti-ICAM-1-
allophycocyanin (APC), and anti-P-selectin-
fluorescein isothiocyanate (FITC). Immuno-stained 
cells were analyzed with a GUAVA Flow Cytometer 
(Millipore).  
 
Tube formation assay 
 
Twelve-well plates containing 400 μL of polymerized 
growth factor-reduced Matrigel (Corning, Bedford, 
MA, USA) were used to validate tube formation  
of endothelial cells. HUVECs in EGM-2 medium  
were plated into Matrigel at a density of 1×10
5
 
cells/well and incubated for 20 h at 37° C. Cultures 
were imaged (40× magnification) after control cells 




HUVEC proliferation was measured using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT, Sigma-Aldrich). HUVECs were seeded into 96-
well plates at a density of 1×10
3
 cells/well. After 1 d, 25 
nM of each siRNA was transfected into HUVECs and 
cultured in EGM-2 for the indicated time. HUVEC 
growth was measured by adding MTT solution (5 
mg/mL) to each culture being assayed to equal one tenth 
of the culture volume, followed by incubation at 37° C 
for 4 h. After removing the medium, the converted 
formazan crystals were solubilized with 0.04 M HCl in 
isopropanol and quantified by optical density at a 
wavelength of 570 nm. The background signal was 
acquired at 690 nm and subtracted from the culture 
measurements.  
 
Microarray analysis  
 
Total RNA was isolated from the HUVECs treated with 
control or SIRT6 siRNA for 3 d using the RNeasy RNA 
isolation kit (Qiagen). Five-hundred nanograms of total 
RNA was used for labeling and hybridization, in 
accordance with the manufacturer’s protocols 
(#AMIL1791, Ambion, Inc.). Labeled RNA was 
hybridized with bead chips, which were then washed 
and scanned with an Illumina Bead Array Reader 
(Illumina, Inc. Sam Diego, CA, USA). The microarray 
data were normalized using the quantile normalization 
method in the Linear Models for Microarray Data 
(LIMMA) package in the R language environment. The 
expression of each gene was transformed into a log2 
base before further analysis. The Ingenuity Pathway 
Analysis program (Redwood City, CA, USA) was used 
to identify specific gene subsets sharing functional 
annotation linking and to analyze specific biological 
and functional pathways. 
 
Cell cycle analysis 
 
Cell cycle analysis was performed using GUAVA Cell 
Cycle Reagent (GUAVA Technologies, Hayward, CA, 
USA) according to the manufacturer’s instructions. 
Briefly, HUVECs transfected with 25 nM of each 
siRNA were incubated in EGM-2 at 37° C for 3 d. Cells 
were harvested with trypsin-EDTA treatment and 
dispersed as single cells. Cells were fixed with ice-cold 
70% (v/v) ethanol and then, incubated in GUAVA Cell 
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Cycle Reagent for 30 min at room temperature. Cell 
cycle phases were analyzed using the GUAVA Flow 




To evaluate DNA damage in a cell, we performed an 
alkaline comet assay using CometAssay kit (Trevigen, 
Gaithersburg, MD, USA) according to the 
manufacturer’s instructions. Briefly, HUVECs 
transfected with 25 nM of control or SIRT6 siRNA were 
incubated in EGM-2 for 3 d. Cells treated with 200 μM 
H2O2 for 1 h were used as positive control. Cells were 
gently detached by trypsin-EDTA treatment and 
suspended at 1 × 10
5
 cells/ml in ice cold PBS. Fifty 
microliter of cells combined with molten LMAgarose at 
a ratio of 1:10 (v/v) were dropped and spread onto 
CometSlide. After gelling LMAgarose, slides were 
treated with lysis solution for 1 h at 4° C and alkaline 
unwinding solution for 20 min at room temperature. The 
slides were placed in electrophoresis tray containing 
alkaline electrophoresis solution and subjected to 
electrophoresis at 21 volts for 40 min. After staining 
cells with SYBR green (Invitrogen), cell images were 
obtained at 200 × magnification using EVOS M5000 
imaging system (Thermo Fisher Scientific). Percent 
DNA in the tail and tail moment from at least 50 
randomly selected cells per sample were analyzed using 




The data are presented as the mean ± standard deviation 
(SD). Statistical significance was evaluated using a 
Student’s t-test and P-values < 0.05 were considered to 
be statistically significant. Two-way ANOVA was used 




SIRT: sirtuin; FOXM1: forkhead box M1; IL: 
interleukin; eNOS: endothelial nitric oxide synthase; 
HUVEC: human umbilical vein endothelial cell; SA β-
gal: senescence-associated β-galactosidase; PD: 
population doubling; PQ: paraquat dichloride x-hydrate; 
Chk: checkpoint kinase; EGM-2: endothelial growth 
medium-2; MOI: multiplicity of infection; DAPI: 4´,6-
diamidino-2-phenylindole. 
 
AUTHOR CONTRIBUTIONS  
 
OHL, YMW, and YYP performed the experiments and 
analyzed the data. SM, JL, HP, and HJ analyzed and 
processed the data. SKB, KHP, and JHH revised the 




Thanks to Dr. Zhou Songyang (Baylor College of 
Medicine, Houston, TX 77030, USA) for providing 
vectors used in this paper. 
 
CONFLICTS OF INTEREST 
 




This research was supported by grants awarded by the 
Basic Science Research Program through the National 
Research Foundation of Korea funded by the Ministry 
of Education (2013R1A1A3011197, 2015R1D1A1 
A01059619, and 2019R1A6A1A03032888) and a grant 
from National Research Foundation of The Ministry of 





1. Donato AJ, Machin DR, Lesniewski LA. Mechanisms of 
dysfunction in the aging vasculature and role in age-
related disease. Circ Res. 2018; 123:825–48. 
 https://doi.org/10.1161/CIRCRESAHA.118.312563 
PMID:30355078 
2. Lakatta EG, Levy D. Arterial and cardiac aging: major 
shareholders in cardiovascular disease enterprises: 
part II: the aging heart in health: links to heart disease. 
Circulation. 2003; 107:346–54. 
 https://doi.org/10.1161/01.cir.0000048893.62841.f7 
PMID:12538439 
3. van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, 
de Boer MR, Ferreira I, Smulders YM, Twisk JW, 
Stehouwer CD. Endothelial dysfunction and low-grade 
inflammation are associated with greater arterial 




4. Jia G, Aroor AR, Jia C, Sowers JR. Endothelial cell 
senescence in aging-related vascular dysfunction. 




5. Uryga AK, Bennett MR. Ageing induced vascular 
smooth muscle cell senescence in atherosclerosis. J 
Physiol. 2016; 594:2115–24. 
 https://doi.org/10.1113/JP270923  
PMID:26174609 
 
www.aging-us.com 20962 AGING 
6. Gardner SE, Humphry M, Bennett MR, Clarke MC. 
Senescent vascular smooth muscle cells drive 
inflammation through an Interleukin-1α-dependent 
senescence-associated secretory phenotype. 
Arterioscler Thromb Vasc Biol. 2015; 35:1963–74. 
 https://doi.org/10.1161/ATVBAHA.115.305896 
PMID:26139463 
7. Rippe C, Blimline M, Magerko KA, Lawson BR, LaRocca 
TJ, Donato AJ, Seals DR. MicroRNA changes in human 
arterial endothelial cells with senescence: relation to 




8. Guarente L. Sir2 links chromatin silencing, metabolism, 
and aging. Genes Dev. 2000; 14:1021–26. 
 PMID:10809662 
9. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, 
Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, 
Alt FW, Zeiher AM, Dimmeler S. SIRT1 controls 
endothelial angiogenic functions during vascular 
growth. Genes Dev. 2007; 21:2644–58. 
 https://doi.org/10.1101/gad.435107 PMID:17938244 
10. Man AW, Li H, Xia N. The role of Sirtuin1 in regulating 
endothelial function, arterial remodeling and vascular 
aging. Front Physiol. 2019; 10:1173. 
 https://doi.org/10.3389/fphys.2019.01173 
PMID:31572218 
11. D’Onofrio N, Servillo L, Balestrieri ML. SIRT1 and SIRT6 
signaling pathways in cardiovascular disease 
protection. Antioxid Redox Signal. 2018; 28:711–32. 
 https://doi.org/10.1089/ars.2017.7178 
PMID:28661724 
12. Man AW, Li H, Xia N. Resveratrol and the interaction 
between gut microbiota and arterial remodelling. 
Nutrients. 2020; 12:119. 
 https://doi.org/10.3390/nu12010119 PMID:31906281 
13. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash 
H, Damian M, Cheung P, Kusumoto R, Kawahara TL, 
Barrett JC, Chang HY, Bohr VA, Ried T, et al. SIRT6 is a 
histone H3 lysine 9 deacetylase that modulates 
telomeric chromatin. Nature. 2008; 452:492–96. 
 https://doi.org/10.1038/nature06736 PMID:18337721 
14. Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 
homolog SIRT6 is a nuclear ADP-ribosyltransferase. J 
Biol Chem. 2005; 280:21313–20. 
 https://doi.org/10.1074/jbc.M413296200 
PMID:15795229 
15. Liu Z, Wang J, Huang X, Li Z, Liu P. Deletion of sirtuin 6 
accelerates endothelial dysfunction and 
atherosclerosis in apolipoprotein E-deficient mice. 
Transl Res. 2016; 172:18–29.e2. 
 https://doi.org/10.1016/j.trsl.2016.02.005 
PMID:26924042 
16. Zi Y, Yi-An Y, Bing J, Yan L, Jing T, Chun-Yu G, Fan P, Hao 
L, Jia-Ni T, Han-Jin H, Fei C, Xue-Bo L. Sirt6-induced 
autophagy restricted TREM-1-mediated pyroptosis in 
ox-LDL-treated endothelial cells: relevance to 
prognostication of patients with acute myocardial 
infarction. Cell Death Discov. 2019; 5:88. 
 https://doi.org/10.1038/s41420-019-0168-4 
PMID:30993014 
17. D’Onofrio N, Servillo L, Giovane A, Casale R, Vitiello M, 
Marfella R, Paolisso G, Balestrieri ML. Ergothioneine 
oxidation in the protection against high-glucose 
induced endothelial senescence: involvement of SIRT1 
and SIRT6. Free Radic Biol Med. 2016; 96:211–22. 
 https://doi.org/10.1016/j.freeradbiomed.2016.04.013 
PMID:27101740 
18. Heiss C, Rodriguez-Mateos A, Kelm M. Central role of 
eNOS in the maintenance of endothelial homeostasis. 
Antioxid Redox Signal. 2015; 22:1230–42. 
 https://doi.org/10.1089/ars.2014.6158 PMID:25330054 
19. Sangwung P, Zhou G, Nayak L, Chan ER, Kumar S, Kang 
DW, Zhang R, Liao X, Lu Y, Sugi K, Fujioka H, Shi H, 
Lapping SD, et al. KLF2 and KLF4 control endothelial 




20. Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M, 
Ouchi Y. Cilostazol inhibits oxidative stress-induced 
premature senescence via upregulation of Sirt1 in 




21. Isaacsson Velho PH, Castro G Jr, Chung CH. Novel 
targeted agents in head and neck squamous cell 




22. Xue L, Chiang L, He B, Zhao YY, Winoto A. FoxM1, a 
forkhead transcription factor is a master cell cycle 
regulator for mouse mature T cells but not double 
positive thymocytes. PLoS One. 2010; 5:e9229. 
 https://doi.org/10.1371/journal.pone.0009229 
PMID:20169079 
23. Macedo JC, Vaz S, Bakker B, Ribeiro R, Bakker PL, 
Escandell JM, Ferreira MG, Medema R, Foijer F, 
Logarinho E. FoxM1 repression during human aging 
leads to mitotic decline and aneuploidy-driven full 
senescence. Nat Commun. 2018; 9:2834. 
 
www.aging-us.com 20963 AGING 
 https://doi.org/10.1038/s41467-018-05258-6 
PMID:30026603 
24. Smirnov A, Panatta E, Lena A, Castiglia D, Di Daniele N, 
Melino G, Candi E. FOXM1 regulates proliferation, 
senescence and oxidative stress in keratinocytes and 
cancer cells. Aging (Albany NY). 2016; 8:1384–97. 
 https://doi.org/10.18632/aging.100988 
PMID:27385468 
25. Choi YW, Nam GE, Kim YH, Yoon JE, Park JH, Kim JH, 
Kang SY, Park TJ. Abrogation of B-Raf
V600E
 induced 
senescence by FoxM1 expression. Biochem Biophys 
Res Commun. 2019; 516:866–71. 
 https://doi.org/10.1016/j.bbrc.2019.06.144 
PMID:31270027 
26. Laoukili J, Stahl M, Medema RH. FoxM1: at the 




27. Zhang X, Zhang L, Du Y, Zheng H, Zhang P, Sun Y, Wang 
Y, Chen J, Ding P, Wang N, Yang C, Huang T, Yao X, et 
al. A novel FOXM1 isoform, FOXM1D, promotes 
epithelial-mesenchymal transition and metastasis 
through ROCKs activation in colorectal cancer. 
Oncogene. 2017; 36:807–19. 
 https://doi.org/10.1038/onc.2016.249  
PMID:27399334 
28. Heiss C, Spyridopoulos I, Haendeler J. Interventions to 
slow cardiovascular aging: dietary restriction, drugs 
and novel molecules. Exp Gerontol. 2018; 109:108–18. 
 https://doi.org/10.1016/j.exger.2017.06.015 
PMID:28658611 
29. Bonkowski MS, Sinclair DA. Slowing ageing by design: 
the rise of NAD
+
 and sirtuin-activating compounds. Nat 
Rev Mol Cell Biol. 2016; 17:679–90. 
 https://doi.org/10.1038/nrm.2016.93 PMID:27552971 
30. Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. 
Cellular senescence, vascular disease, and aging: part 2 
of a 2-part review: clinical vascular disease in the 
elderly. Circulation. 2011; 123:1900–10. 
 https://doi.org/10.1161/CIRCULATIONAHA.110.00911
8 PMID:21537006 
31. Kawahara TL, Michishita E, Adler AS, Damian M, Berber 
E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY, 
Chua KF. SIRT6 links histone H3 lysine 9 deacetylation 
to NF-kappaB-dependent gene expression and 
organismal life span. Cell. 2009; 136:62–74. 
 https://doi.org/10.1016/j.cell.2008.10.052 
PMID:19135889 
32. Tseng AH, Shieh SS, Wang DL. SIRT3 deacetylates 
FOXO3 to protect mitochondria against oxidative 
damage. Free Radic Biol Med. 2013; 63:222–34. 
 https://doi.org/10.1016/j.freeradbiomed.2013.05.002 
PMID:23665396 
33. Guo J, Wang Z, Wu J, Liu M, Li M, Sun Y, Huang W, Li Y, 
Zhang Y, Tang W, Li X, Zhang C, Hong F, et al. 
Endothelial SIRT6 is vital to prevent hypertension and 
associated cardiorenal injury through targeting Nkx3.2-
GATA5 signaling. Circ Res. 2019; 124:1448–61. 
 https://doi.org/10.1161/CIRCRESAHA.118.314032 
PMID:30894089 
34. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, 
Seluanov A, Gorbunova V. SIRT6 promotes DNA repair 




35. Tian X, Firsanov D, Zhang Z, Cheng Y, Luo L, Tombline 
G, Tan R, Simon M, Henderson S, Steffan J, Goldfarb A, 
Tam J, Zheng K, et al. SIRT6 is responsible for more 
efficient DNA double-strand break repair in long-lived 
species. Cell. 2019; 177:622–38.e22. 
 https://doi.org/10.1016/j.cell.2019.03.043 
PMID:31002797 
36. Rezazadeh S, Yang D, Biashad SA, Firsanov D, Takasugi 
M, Gilbert M, Tombline G, Bhanu NV, Garcia BA, 
Seluanov A, Gorbunova V. SIRT6 mono-ADP ribosylates 
KDM2A to locally increase H3K36me2 at DNA damage 
sites to inhibit transcription and promote repair. Aging 
(Albany NY). 2020; 12:11165–84. 
 https://doi.org/10.18632/aging.103567 
PMID:32584788 
37. Lam AK, Ngan AW, Leung MH, Kwok DC, Liu VW, Chan 
DW, Leung WY, Yao KM. FOXM1b, which is present at 
elevated levels in cancer cells, has a greater 




38. Wang X, Quail E, Hung NJ, Tan Y, Ye H, Costa RH. 
Increased levels of forkhead box M1B transcription 
factor in transgenic mouse hepatocytes prevent age-
related proliferation defects in regenerating liver. Proc 
Natl Acad Sci USA. 2001; 98:11468–73. 
 https://doi.org/10.1073/pnas.201360898 
PMID:11572993 
39. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, 
Park HJ, Tan Y, Ackerson T, Costa RH. Forkhead box M1 
regulates the transcriptional network of genes 
essential for mitotic progression and genes encoding 





www.aging-us.com 20964 AGING 
40. Maciag T, Hoover GA, Stemerman MB, Weinstein R. 
Serial propagation of human endothelial cells in vitro. J 
Cell Biol. 1981; 91:420–26. 
 https://doi.org/10.1083/jcb.91.2.420 PMID:7309790 
41. Lee OH, Kim H, He Q, Baek HJ, Yang D, Chen LY, Liang J, 
Chae HK, Safari A, Liu D, Songyang Z. Genome-wide YFP 
fluorescence complementation screen identifies new 
regulators for telomere signaling in human cells. Mol 
Cell Proteomics. 2011; 10:M110.001628. 
 https://doi.org/10.1074/mcp.M110.001628 
PMID:21044950 
42. Gyori BM, Venkatachalam G, Thiagarajan PS, Hsu D, 
Clement MV. OpenComet: an automated tool for 













Supplementary Figure 1. Effects of SIRT6 knockdown on senescence, proliferation, and FOXM1 expression of HUVECs.  
(A) Real time RT-PCR analysis to examine whether SIRT6 siRNAs, siSIRT6 and siSIRT6*, could efficiently inhibit SIRT6 expression. Total RNA 
was isolated from cells 3 d after siRNA (25 nM) transfection. (B) Western blot analysis showing that both siSIRT6 and siSIRT6* reduced SIRT6 
protein expression. (C) The representative images obtained from SA β-gal-stained HUVECs. The cells transfected with SIRT6 siRNA (25 nM) 
were re-transfected with the siRNA 3 d after the first siRNA treatment. After 6 d from the first transfection, cells were stained for SA β-gal. (D) 
The percentage of SA β-gal-positive senescent HUVECs. The data are shown as the mean ± SD (n = 3). *P < 0.05 or **P < 0.01 vs. control siRNA 
(E) Number of living HUVECs at the indicated time after 25 nM siRNA transfection. Trypsin-EDTA treated HUVECs were stained with trypan 
blue (0.4%, 1:1 dilution), and the number of living cells was measured using hemocytometer. The data are shown as the mean ± SD  
(n = 3). *P < 0.01 vs. control siRNA (F) Real time RT-PCR analysis indicating that SIRT6 knockdown inhibited FOXM1 expression in HUVECs. 
Total RNA was isolated from cells 3 d after siRNA transfection. 
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Supplementary Figure 2. Western blot analysis for phosphorylated p53 expressions in SIRT6 siRNA-treated HUVECs. HUVECs 
were treated with 200 μM H2O2 for 1 h or transfected with 25 nM control or SIRT6 siRNA. After 1 or 3 d. total protein was isolated from cells. 




Supplementary Figure 3. FOXM1 isoforms expressed in HUVECs. (A) Diagram of FOXM1 precursor and spliced mRNAs. The primers, 
P1, P2, P3, and P4, to identify the FOXM1 isoforms have been shown. (B) RT-PCR analysis showing a 250 bp fragment containing Va exon and 
a 493 bp fragment containing VIla exon. Total RNA was isolated from HUVEC, 293T, and HeLa cells. The pENTR/D-TOPO vector containing 
FOXM1C sequence was used as a control. HUVECs predominantly expressed FOXM1C isoform. *, non-specific PCR fragments. 
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Supplementary Table 
 
Please browse Full Text version to see the data of Supplementary Table 1. 
 
Supplementary Table 1. Gene list of differentially expressing genes in SIRT6 siRNA-treated HUVECs compared to 
control cells. 
